Dr. Cress group demonstrated that the cleavage of integrin α6β1 by the serine protease urokinase plasminogen activator (uPA) induces tumor cell motility, invasion, and metastasis in a xenograft model of PCa cells placed within the living bone matrix (53). Here, PLAU is linked to posterior cortical atrophy.